The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma.
Transl Oncol
; 22: 101448, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35660848
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Transl Oncol
Year:
2022
Type:
Article
Affiliation country:
United States